AR and prostate adenocarcinoma: To determine the clinical relevance of these findings, we performed similar scRNA-seq based approaches on a clinical sample isolated from a patient at New York-Presbyterian Hospital/Weill Cornell Medicine who presented with AR-positive prostate adenocarcinoma and AR-negative NEPC liver metastasis.